Skip to main content
Equibles

SEI INVESTMENTS CO

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 350894 OAKS, PA
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,073,102
+$5,143,733 QoQ
Shares Held
211,833
+130.0% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 311 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,273,690,748 across 210 Biotechnology names. RARE ranks #36 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 255,073 $236,649,076
2 INSM
INSMED Inc
 1,015,870 $108,312,059
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 129,981 $64,565,461
4 EXEL
Exelixis, Inc.
 1,166,715 $63,480,962
5 ASND
Ascendis Pharma A/S
 237,869 $63,444,419
6 INCY
Incyte Corp
 498,013 $56,454,752
7 HALO
Halozyme Therapeutics, Inc.
 551,116 $43,135,848
8 REGN
Regeneron Pharmaceuticals, Inc.
 60,441 $37,687,380

All Filings in RARE

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,073,102 211,833
2026-03-31 $1,929,369 92,094
2025-12-31 $3,535,698 153,726
2025-09-30 $5,729,096 190,462
2025-06-30 $3,279,380 90,192
2025-03-31 $4,063,268 112,214
2024-12-31 $4,135,859 98,309
2024-09-30 $6,451,409 116,137
2024-06-30 $3,772,938 91,799
2024-03-31 $3,081,352 65,996
2023-12-31 $3,126,471 65,380
2023-09-30 $1,980,427 55,552
2023-06-30 $3,033,231 65,754
2023-03-31 $2,279,684 56,850
2022-12-31 $3,201,680 69,106
2022-09-30 $2,273,698 54,907
2022-06-30 $1,668,630 27,969
2022-03-31 $1,893,202 26,070
2021-12-31 $319,794 3,803
2021-03-31 $1,677,954 14,737
2020-12-31 $2,042,810 14,757
2020-09-30 $1,895,300 23,060
2020-06-30 $2,721,039 34,787
2020-03-31 $1,760,849 39,632